- Timesulin Approved for Reimbursement from Canadian Insurance Companies
Montréal, QC August 22, 2014: In a move that will benefit millions of people with diabetes, 9 of the largest health insurers in Canada have approved Timesulin as a reimbursable product.
This is an exciting decision for the diabetes community as the cost of managing diabetes has increased tremendously over the last few decades, making it difficult for everyone to have access to important, life-saving technology and healthcare. By making the Timesulin insulin pen replacement cap reimbursable, Canada is helping lead the charge to reduce the health and economic consequences of diabetes and ensure more peace of mind for everyone living with diabetes.
The insurance companies that have approved Timesulin for reimbursement include:
- Great West Life
- Manulife Financial